Drugs containing Von Willebrand Factor: Vonvendi, Humate-P, Alphanate, Wilate, Wilfactin, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Von Willebrand Factor Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of von Willebrand factor during breastfeeding. Because it is a large protein molecule, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, von Willebrand factor should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Von Willebrand Factor
CAS Registry Number
109319-16-6
Drug Class
Breast Feeding
Lactation
Blood Coagulation Factors
Coagulants
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
